The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Artificial Intelligence (AI) Pathology Quality Control Market Change Between 2026 And 2030?
The artificial intelligence (AI) pathology quality control market has witnessed significant expansion in recent years. It is projected to grow from $1.78 billion in 2025 to $2.16 billion in 2026, achieving a compound annual growth rate (CAGR) of 21.4%. This historical expansion can be ascribed to several factors, including increasing pathology workload volumes, the early digitization of pathology slides, the growing complexity of cancer diagnostics, a demand for standardized reporting, and the initial adoption of AI-assisted pathology tools.
The artificial intelligence (AI) pathology quality control market is anticipated to experience substantial growth in the coming years. It is expected to reach $4.65 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 21.1%. The expansion during this forecast period can be attributed to increased investments in digital pathology platforms, a rising need for precision diagnostics, the broader application of AI validation in clinical workflows, the deepening integration of pathology data analytics, and a stronger regulatory focus on ensuring diagnostic quality control. Key trends during the forecast period include the wider deployment of AI-based slide quality assessment, the growing adoption of automated error detection tools, the increasing standardization of pathology workflows, the expanded integration of digital pathology, and a heightened emphasis on guaranteeing diagnostic accuracy.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28124&type=smp
What Major Growth Factors Are Impacting The Artificial Intelligence (AI) Pathology Quality Control Market?
Growing demand for personalized medicine is projected to drive the expansion of the artificial intelligence (AI) pathology quality control market in the future. This medical strategy customizes treatment and preventative measures based on an individual’s distinct genetic profile, lifestyle choices, and environmental factors. Its rising acceptance stems mainly from genomic progress, allowing for accurate identification of genetic differences and bespoke therapies for individuals. Artificial intelligence (AI) pathology quality control improves personalized medicine by providing accurate and uniform diagnostic data, which facilitates customized treatment plans. This technology minimizes diagnostic inaccuracies through automated quality assessments, boosting precision and dependability, thereby furthering patient-specific healthcare. As an illustration, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) sanctioned 26 new personalized medicines in 2023, marking a considerable rise from the 12 approved in 2022. Consequently, the escalating need for personalized medicine will fuel the artificial intelligence (AI) pathology quality control market.
Which Segment Groups Define The Artificial Intelligence (AI) Pathology Quality Control Market Landscape?
The artificial intelligence (AI) pathology quality control market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: On-Premises, Cloud-Based
3) By Application: Cancer Diagnostics, Infectious Disease Diagnostics, Digital Pathology, Research, Other Applications
4) By End-User: Hospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical And Biotechnology Companies, Other End Users
Subsegments:
1) By Software: Image Analysis Software, Diagnostic Decision Support Software, Workflow Management Software, Reporting And Visualization Software
2) By Hardware: Digital Pathology Scanners, Imaging Devices, Servers And Storage Systems, Laboratory Equipment
3) By Services: Implementation Services, Training And Support Services, Maintenance And Upgrade Services, Consulting Services
What Trends Are Shaping The Artificial Intelligence (AI) Pathology Quality Control Market Structure?
Leading companies in the artificial intelligence (AI) pathology quality control market are prioritizing the development of sophisticated solutions designed to improve diagnostic precision, optimize laboratory operations, and uphold the reliability of pathology data. These advanced AI-powered solutions signify next-generation technologies that leverage artificial intelligence to perform complex assignments with increased accuracy, speed, and overall efficiency. For instance, in November 2023, the US-based biotechnology company PathAI released Artifact Detect 1 on its AISight digital pathology platform. This tool autonomously identifies and quantifies artifacts within whole slide images (WSI), which are non-pertinent morphological features capable of compromising diagnostic accuracy. ArtifactDetect works by automatically pre-screening slides for quality issues, thereby minimizing misdiagnosis and the necessity for rescans, ultimately enhancing accuracy, laboratory efficiency, and overall throughput. This innovation supports prompt corrective actions such as re-staining or re-scanning, contributing to an improved digital workflow and resource conservation for technicians and pathologists alike.
Who Are The Prominent Players Across The Artificial Intelligence (AI) Pathology Quality Control Market?
Major companies operating in the artificial intelligence (AI) pathology quality control market are Roche Diagnostics GmbH, Danaher Corporation, Philips Healthcare, Agilent Technologies Inc., Hologic Inc., Clinisys Group Ltd., Sectra AB, PathAI Inc., OptraSCAN Inc., Paige.AI Inc., Proscia Inc., Quibim S.L., 3DHISTECH Ltd., Visiopharm A/S, Indica Labs Inc., Ibex Medical Analytics Ltd., Aiosyn B.V., DeepBio Inc., Nucleai Ltd., Gestalt Diagnostics LLC
Access The Complete Artificial Intelligence (AI) Pathology Quality Control Market Report:
Which Region Is The Dominant Market In The Artificial Intelligence (AI) Pathology Quality Control Market?
North America was the largest region in the artificial intelligence (AI) pathology quality control market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (AI) pathology quality control market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Artificial Intelligence (AI) Pathology Quality Control Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=28124&type=smp
Browse Through More Reports Similar to the Global Artificial Intelligence (AI) Pathology Quality Control Market 2026, By The Business Research Company
Ai In Medical Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-diagnostics-global-market-report
Ai In Cancer Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-cancer-diagnostics-global-market-report
Artificial Intelligence In Healthcare Diagnosis Global Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
